DNRV_STRPE
ID DNRV_STRPE Reviewed; 275 AA.
AC Q9ZAU2;
DT 19-MAR-2014, integrated into UniProtKB/Swiss-Prot.
DT 01-MAY-1999, sequence version 1.
DT 25-MAY-2022, entry version 41.
DE RecName: Full=Anthracycline biosynthesis protein DnrV;
GN Name=dnrV;
OS Streptomyces peucetius.
OC Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC Streptomyces.
OX NCBI_TaxID=1950;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC STRAIN=ATCC 29050 / DSM 40754 / JCM 9920 / NBRC 100596 / NCIMB 10972;
RX PubMed=9864344; DOI=10.1128/jb.181.1.305-318.1999;
RA Lomovskaya N., Otten S.L., Doi-Katayama Y., Fonstein L., Liu X.-C.,
RA Takatsu T., Inventi A., Filippi S., Torti F., Colombo A.L.,
RA Hutchinson C.R.;
RT "Doxorubicin overproduction in Streptomyces peucetius: cloning and
RT characterization of the dnrU ketoreductase and dnrV genes and the doxA
RT cytochrome P-450 hydroxylase gene.";
RL J. Bacteriol. 181:305-318(1999).
CC -!- FUNCTION: Involved in the biosynthesis of the anthracyclines
CC carminomycin and daunorubicin (daunomycin) which are aromatic
CC polyketide antibiotics that exhibit high cytotoxicity and are widely
CC applied in the chemotherapy of a variety of cancers. In vivo, it acts
CC jointly with DoxA in the conversion of 13-deoxycarminomycin and 13-
CC deoxydaunorubicin to yield carminomycin and daunorubicin, respectively.
CC In vitro, it also acts jointly with DoxA in the C-14 hydroxylation of
CC daunorubicin to form doxorubicin, although this strain is not a
CC doxorubicin producer. {ECO:0000269|PubMed:9864344}.
CC -!- PATHWAY: Antibiotic biosynthesis; daunorubicin biosynthesis.
CC -!- PATHWAY: Antibiotic biosynthesis; carminomycin biosynthesis.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U77891; AAD04716.1; -; Genomic_DNA.
DR AlphaFoldDB; Q9ZAU2; -.
DR SMR; Q9ZAU2; -.
DR UniPathway; UPA00054; -.
DR UniPathway; UPA01040; -.
DR GO; GO:1901771; P:daunorubicin biosynthetic process; IMP:UniProtKB.
DR Gene3D; 3.10.180.10; -; 2.
DR InterPro; IPR029068; Glyas_Bleomycin-R_OHBP_Dase.
DR InterPro; IPR004360; Glyas_Fos-R_dOase_dom.
DR InterPro; IPR041581; Glyoxalase_6.
DR InterPro; IPR037523; VOC.
DR Pfam; PF00903; Glyoxalase; 1.
DR Pfam; PF18029; Glyoxalase_6; 1.
DR SUPFAM; SSF54593; SSF54593; 2.
DR PROSITE; PS51819; VOC; 2.
PE 4: Predicted;
KW Antibiotic biosynthesis; Repeat.
FT CHAIN 1..275
FT /note="Anthracycline biosynthesis protein DnrV"
FT /id="PRO_0000425686"
FT DOMAIN 8..136
FT /note="VOC 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01163"
FT DOMAIN 150..263
FT /note="VOC 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01163"
SQ SEQUENCE 275 AA; 28481 MW; DEE13C0E714D4397 CRC64;
MTRFAPGAPA WFDLGSPDVA ASADFYTGLF GWTATVVSDP GAGGYTTFSS DGKLVAAVAR
HQIDTPYHRP YGPGNDQHGM PAIWTVYFAT DDADALTKRV ETAGGEVIMT PMDVLGLGRM
AVFADPAGAA FAVWRKGVME GAEVTGVPGS VGWVELVTDG IGAARDFYPA TLGLAPADTG
LKGVTDPVWH IGDTPVAGTQ ELGVTGAVRP HWAVLFAVHD CDATVRRAVE LGGSVENEPA
DTPRGRRADL LDPHGAGFSV VELREGYPAA AGGAS